Provention Bio drug for delaying type 1 diabetes hit with FDA delay of its own,

A larger study testing the prospective type 1 diabetes therapy teplizumab is ongoing and could provide the information the agency needs. By Frank …, A larger study testing the prospective type 1 diabetes therapy teplizumab is ongoing and could provide the information the agency needs. By Frank …, Read More

Scroll to Top